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Structural Heart Disease 
a b s t r a c t 
With innovations in therapeutic technologies and changes in population demographics, transcatheter in- 
terventions for structural heart disease have become the preferred treatment and will keep growing. Yet, 
a thorough clinical selection and efficient pathway from diagnosis to treatment and follow-up are manda- 
tory. In this review we reflect on how artificial intelligence may help to improve patient selection, pre- 
procedural planning, procedure execution and follow-up so to establish efficient and high quality health 
care in an increasing number of patients. 
© 2021 erasmus mc. Published by Elsevier Inc. 


































The demand for Transcatheter Interventions for Structural Heart 
isease (SHD) will increase given age-associated accretion of 
alvular heart disease, atrial fibrillation (AF) and stroke and in- 
essant innovations in technology [ 1 , 2 ]. This calls for a more re-
ned process of data analysis along the entire clinical pathway 
rom treatment decision and planning to execution and follow-up 
o ensure a cost-effective and patient-tailored (precision) medicine. 
ince Artificial Intelligence (AI) enables computers to perform tasks 
raditionally performed by humans in a faster and potentially more 
recise fashion, it may be the tool to achieve this goal and is the 
ubject of this paper [3–7] . 
oncepts and definitions 
Artificial Intelligence is a field of computer science enabling 
omputers to perform tasks that traditionally could only be carried ∗ Corresponding author. 
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ects such as machine learning (ML), natural language processing 
NLP), computer vision and cognitive computing ( Central Illustra- 
ion , Supplementary Table ) [7] . 
Machine Learning is the process by which the computer 
s taught by supervised, unsupervised or reinforcement learning 
 Table 1 ) [3–11] . Deep Learning (DL) is a branch of ML (super-
ised or unsupervised) based on artificial neural networks (ANN’s) 
omposed of “neurons” arranged in multiple layers. Each neuron 
eceives inputs from multiple neurons in the previous layer and 
ransmits outputs to multiple neurons in the next layer until a fi- 
al (“desired”) output is produced ( Fig. 1 ) [3–7] . The number of 
ayers and structure of their inter-connection define the network 
rchitecture, as different architectures may be appropriate for dif- 
erent tasks. For instance, convolutional neural networks are partic- 
larly suited for segmentation tasks, whereas recurrent neural net- 
orks are more suited for processing of sequential data (e.g. cine- 
maging) [12] . The complex interactions between layers allow the 
omputer to learn features (e.g. edge detection) for data process- 
ng and interpretation. This is not possible with traditional ML al- 
orithms, where features have to be programmed by humans (fea- nder the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ) 
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Supervised Learning • The computer learns by being exposed to a dataset in 
which the input-output relationship is known (e.g. 
anatomic structure of interest is annotated for image 
analysis; outcome is labelled for prognosis prediction) 
• The output is manually annotated in the training 
dataset (requiring significant human interaction) 
• Once trained, the algorithm is able to predict the output 
from an unlabelled dataset 
Example : 
• The computer is given an input of CT images in which 
the aortic annulus has been manually annotated (labelled 
output, ground truth), until it learns to identify the aortic 
annulus form an unlabelled set of images 9 
Relevance of previous example 
• Reduced time of imaging processing 
• Reduced inter- and intra-observer variability 
Unsupervised Learning • The computer learns to detect certain patterns within 
an unlabelled dataset (minimal human interaction) 
Example: 
• The computer is exposed to a data set composed of 
clinical variables concerning patients with aortic stenosis 
and automatically identifies clusters of phenotypes that 
resemble each other ( ie . alike vs not alike), that may be 
associated with a different outcome and demand a 
specific treatment/clinical approach 10,11 
Relevance of previous example 
• The different disease/patient phenotypes may confer 
different prognoses and/or response to treatment and 
thus have implications in treatment decisions 
Reinforcement Learning • The computer is trained in a trial and error fashion, 
where each outcome is positively or negatively rewarded 
accordingly to whether it is right or wrong 
• Currently seldom applied in medicine 
Example 
• The computer selects a given valve size for a given 
anatomy, is confronted with the outcome (positive vs 
negative) therefore positively or negatively rewarding the 
initial treatment decision, and ultimately learns to make 
the right clinical decision for each specific anatomy. 
Comment : There is neither clinical experience nor study 
in the use of reinforcement learning in structural heart 
disease yet 
Relevance of previous example 
• Automation and refinement of treatment algorithms 
Fig. 1. Schematic of a Deep Learning network. Artificial neurons (top left) receive inputs that are multiplied by their weight and summed to produce an output. Artificial 
neuron networks are composed by multiple neurons arranged in layers – input layers, hidden layers and output layers. Input layers process and transmit inputs from the 
dataset to the hidden layers. In the hidden layers, each neuron receives inputs from multiple neurons in the previous layers and transmits its output to multiple neurons 
in the next layer. The depth of the network (e.g. number of hidden layers) and architecture (e.g. arrangement & connections) confers each network specific characteristics 























ure engineering) [ 4 , 5 ]. DL allows the generation of new features
hat may remain undetected by humans [13] . This renders DL par- 
icularly efficient in processing graphic data and hence the analysis 
f (medical) images. The complexity of DL algorithms, however, de- 
ands substantial computer power for processing and storing (e.g. 
raphics processing units (GPU), cloud computing) [ 3–7 , 12 , 14 ]. 
Big Data refers to a large amount of complex multidimen- 
ional data that is hard to process using traditional methods, of 
hich medical data are exemplary. The digitalization of health- 
ecords requires the integration of information from medical files 
lus surveillance from remote devices (e.g. wearables) and “omics”
oncerning millions of patients [3] . Because ML and DL rely on ex- 2 erience (i.e. the more extensive the training dataset, the more ac- 
urate the algorithm) and process a large amount of information, 
ig data and AI are interdependent ( Central Illustration ). For in- 
tance, weakly supervised ML (minimal human interaction) effec- 
ively labelled aortic valve abnormalities from MRI sequences of 
 14,0 0 0 subjects [15] . 
Similar to traditional statistics, the data set used to construct 
L and DL algorithms needs to meet the criteria of quality and 
ompleteness to adequately address the research/clinical question. 
he data need to be multidimensional, relevant and of high quality. 
hile robotics, NLP and other technologies can be used for auto- 
ated extraction of data from patient files, the variability between 
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Fig. 2. Schematic of the application of Artificial Intelligence for Transcatheter Interventions for Structural Heart Disease. 


































linical registries hinders data fidelity. Also ML, and particularly 
L, are prone to overfitting when too many “noisy” or “confound- 
ng” variables are present or when the algorithm is too complex 
or a dataset, resulting in algorithms that are unreliable outside 
he scope of the training and testing data and, therefore, invalid 
n other populations [ 16 , 17 ]. Moreover, the incorporation of a large
olume of data increases model complexity and processing time 
hat may render them inefficient, particularly in case of supervised 
earning. In such cases, appropriate variable selection is mandatory 
o retain the most useful information while maintaining model re- 
roducibility [ 11 , 18 ]. 
Natural Language Processing recognizes and discerns the 
eaning of speech or text in particular when empowered by DL 
 7 , 19 ]. NLP is useful in identifying relevant data from patient files
nd scientific publications potentially enforcing clinical decision- 
aking [20–22] . 
Computer Vision focuses on image/video interpretation and ob- 
ect recognition and is particularly useful to automatically detect 3 bnormalities (e.g. tumors) or specific anatomical structures based 
n differences in pixel features, useful for automated quantitative 
nalysis or generation of 3D models [ 7 , 19 ]. 
Cognitive computing encompasses NLP, computer vision and 
L. It seeks to mimic the human process of decision-making by 
eaching the computer to acknowledge information from multi- 
le sources (image, sound, text,) and interpret such information in 
ight of previous experience (associative memory) [ 3 , 23 , 24 ]. By ac-
ounting for previous experience in the decision process, cognitive 
omputing goes beyond most ML algorithms that rely only on log- 
cal thinking. Sengupta et al. used speckle-tracking and standard 
chocardiographic variables from 94 patients with either restric- 
ive cardiomyopathy or constrictive pericarditis (the diagnosis was 
ased on multimodality imaging, right heart catheterization and, 
or constriction, at the time of pericardiectomy) to build an ML- 
ased associative memory classifier that included the most power- 
ul predictors of each diagnosis, with excellent diagnostic accuracy 
area under the curve 96%) [25] . 
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rtificial Intelligence Applied to Transcatheter Interventions for 
tructural Heart Disease ( Figs. 2 and 3 ) 
iagnosis and treatment selection 
Unsupervised Learning : Currently, indications for valvular 
eart intervention are based mainly on echocardiographic findings 
nd symptoms whereas recommendations for interventions such 
s left atrial appendage occlusion (LAAO) rely on estimated is- 
hemic (i.e. stroke) and bleeding risks [ 26 , 27 ] The contemporary 
uidelines are strict and limited since they are based on a lim- 
ted number of variables collected from a limited number of stud- 
es and, thus, pertaining to selected populations. Although they are 
asy to implement and reflect the strongest prognostic factors re- 
orted to date, they may omit other factors that may remain elu- 
ive to conventional statistical analyses. This can be addressed by 
luster Analysis, which refers to unsupervised ML algorithms that 
ave the power to elicit hidden patterns/associations within the 
nown data and, hence, to identify various patient/disease pheno- 
ypes with different outcomes ( Table 1 ). Such algorithms can help 
o improve appropriateness of care (precision medicine) by iden- 
ifying phenotypes associated with a benign outcome that do not 
arrant treatment, those at high risk for whom treatment is indi- 
ated and those with advanced disease state for whom treatment 
s futile or even harmful. In other words, they can elicit hetero- 
eneous treatment effects in patients with the same disease (e.g. 
ortic stenosis). This has been demonstrated by Kwak et al., who 
ound three different aortic stenosis (AS) phenotypes with differ- 
nt outcomes; one with predominant cardiac dysfunction and high 
ardiovascular mortality, one comprising mostly elderly and in- 
reased cardiac and non-cardiac mortality and a third cluster of 
ainly “healthy” AS patients with a benign prognosis [11] . Simi- 
arly, topological data analysis of cross-sectional echocardiographic 
ata identified two pathways of progression from mild to severe 
S: one associated with preserved left ventricle (LV) function and 
ittle LV hypertrophy and the other with depressed LV function and 
ncreased LV mass [10] . Similar findings of different outcomes in 
arious disease phenotypes have been found in patients with mi- 
ral valve prolapse and AF [28–30] . Conceptually, Cluster Analysis 
ay help to refine treatment selection for patients with valve dis- 
ase (catheter-based treatment vs surgery, mitral valve repair or 
eplacement) and AF (differentiation of risk of stroke with specific 
AA anatomies). 
Supervised Learning : While unsupervised ML is particularly 
elpful for the identification of patterns of associations (pheno- 
ype/outcome) within a population, supervised ML is an alter- 
ative to conventional statistics to identify prognostic predictors 
 Table 1 ). Unlike Cluster Analysis, where the computer identifies 
istinct groups of patients based on their characteristics irrespec- 
ive of the outcomes (i.e. the computer is unaware of any data clas- 
ification), supervised ML serves to identify relationships between 
he input data and a specific outcome [ 4 , 14 ]. It typically produces
tronger prediction models than conventional statistics, by relying 
n fewer assumptions and being able to learn relationships within 
he data that escape human comprehension [ 8 , 14 ]. Also, and at
ariance with conventional logistic regression, it allows the identi- 
cation of linear but also non-linear associations between the data 
ithin a large multidimensional data set such as a biologic one 
17] . As mentioned above, AI algorithms are not free of bias. They 
epend upon the quality, relevance and completeness of the data. 
upervised ML has been used to predict stroke in AF and outcomes 
fter TAVI. Currently, the accuracy of these algorithms still limits 
heir application in clinical practice [ 31 , 32 ]. It has also been pro-
osed to facilitate an early diagnosis of AS, as it can predict signif- 
cant AS from ECG analysis [33] . a
4 Application of AI, and particularly DL to automate image anal- 
sis (interpretation and quantification) allows faster imaging pro- 
essing with less intra- and inter-observer variability. This is of 
articular relevance for prevalent diseases whose diagnoses heav- 
ly rely on imaging (e.g. valve disease). Most AI algorithms are di- 
ected towards the automated segmentation of echocardiographic, 
T and MRI images allowing a fast (within seconds) and accurate 
tructure recognition and delineation (e.g. valves, LV borders) or 3D 
odel generation [ 9 , 34–43 ]. This is relevant for procedural plan- 
ing (see below), by facilitating structure measurements and 3D 
odel generation to be used for patient-specific computer model- 
ng and simulation (CM&S), thereby, improving treatment planning 
nd execution. It also allows the quantification of volumes, flow 
nd ejection fraction aiding diagnosis and disease severity deter- 
ination [ 3 , 9 , 36 , 40 , 44 ]. 
Knackstedt et al. used ML empowered analysis of echocardio- 
raphic images for automatic quantification of ejection fraction and 
ongitudinal strain and reported a good agreement with the man- 
ally tracked ejection fraction and longitudinal strain (processing 
ime ~8 s) [37] . Models for automated assessment of valvular heart 
isease also showed encouraging results [ 45 , 46 ]. Playford et al. 
eveloped an echocardiography-based AI algorithm to diagnose se- 
ere aortic stenosis while overcoming the limitations inherent to 
V outflow tract measurements. AI predicted a greater survival 
ifference between severe versus non-severe aortic stenosis than 
raditional measurements, while more frequently labeling “severe 
S” that traditional methods [47] . It remains unclear whether this 
hould trigger an earlier intervention or be regarded as co-existing 
eart disease such as age-related diastolic dysfunction. 
Cognitive computing proved useful to differentiate restrictive 
ardiomyopathy and constrictive pericarditis (vide supra) [25] . Al- 
orithms integrating imaging plus other relevant clinical data could 
urther refine the diagnostic process in a manner that more closely 
esembles the physician’s clinical thinking, where clinical, labora- 
ory, imaging data and more come into play [ 3 , 12 ]. 
reatment planning and guidance 
ML allows fully- or semi-automated identification and quantifi- 
ation of anatomic structures as a result of which tasks such as 
ortic (annulus) measurements for valve selection for TAVI will be- 
ome less time-consuming and more efficient. Automated perime- 
er measurement of the aortic and mitral annulus is feasible within 
econds and with an error similar or smaller than the one of dif- 
erent operators (i.e. within inter-observer variability) [ 9 , 34 , 41 , 48 ].
ig. 4 shows an example of how the computer is taught to recog- 
ize the aortic annulus from CT images (labelled dataset) until it 
earns to execute this task in an unlabelled dataset. 
ML also enhances the generation of 3D computer models for 
imulation, streamlining the process of selection of the device that 
est fits the individual patient. ML minimizes variability of mea- 
urement next to time efficiency, while CM&S predicts valve per- 
ormance and complications as it assesses device/host interaction. 
his has been validated for TAVI and shown for transcatheter mi- 
ral valve replacement (TMVR), mitraclip procedures and LAA oc- 
lusion [49–55] . Of note, it not only affects device selection (size, 
ype) but also procedural technique such as depth-of-implantation 
o prevent conduction abnormalities (TAVI) or neoLVOT (TMVR) 
 56 , 57 ]. Enhancement and refinement of such models by ML could 
romote a more widespread implementation in clinical practice, 
hich would be of particular relevance for procedures that are per- 
ormed less frequently and for which the experience is low, such 
s TMVR, or for lower-volume centers with less experienced oper- 
tors. 
ML has also been applied to enhance fusion-imaging for guid- 
nce of transcatheter SHD interventions. Fluoroscopy has lim- 
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Fig. 4. Overview of a method to predict TAVI prosthesis sizes from the aortic annu- 
lar plane (AAP). The model predicts the probability plane from the original AAP. The 
contours are detected, and the predicted area and perimeter are compared with the 
ground truth. 
GT – Ground truth 
Reproduced from reference 36. 
Central Illustration. Relationship between Artificial Intelligence (AI) and Big Data. 
AI and its subfields (Machine Learning, Deep Learning, Natural Language Process- 
ing, Computer Vision and Cognitive Computing) rely on Big Data, which, in turn, 
requires sophisticated AI-algorithms for processing. Big Data are multidimensional 
and from many sources concerning patients details (left arrow) but also originating 













































































ted ability to differentiate soft tissue structures and fusion with 
chocardiography or CT provides more anatomic detail. By facilitat- 
ng the segmentation process and allowing structure recognition, 
I enables superimposition of two different imaging techniques 
nd allows automatic identification of landmark anatomic struc- 
ures relevant for correct valve/device implantation [ 4 , 7 , 35 , 58 ]. Fu-
ion of 3D transesophageal echocardiography with fluoroscopy has 
een used to guide TAVI and transcatheter LAAO, possibly reducing 
rocedural time and radiation [ 59 , 60 ]. CT-fluoroscopy imaging has 
roved useful to guide transapical access for complex interventions 
uch as mitral valve-in-valve, PVL occlusion or ventricular septal 
efect occlusion [61] . Procedural guidance/planning may even be 
aken a step forward by the utilization of augmented reality, where 
ifferent imaging modalities (eg. fluoroscopy and CT) are combined 
o generate holograms allow real-time 3-dimensional visualization 
f cardiac structures and catheter [62] . 5 rognosis, surveillance and rehabilitation 
A premise for establishing a patient-oriented efficient and cost- 
ffective surveillance program is that patients at a high risk of 
dverse events, who will be the target of more rigorous, time- 
nd resource-consuming follow-up surveillance, are accurately sep- 
rated from those at a lower risk. ML has already been shown to 
utperform classical statistical methods to predict outcomes in the 
atient with heart failure, coronary artery disease and congenital 
eart disease [63–66] . Recently, Hernandez-Suarez et al. used su- 
ervised ML to predict in-hospital mortality after TAVI and TMVR 
ith an accuracy surpassing that of previous models [ 67 , 68 ]. , Pre-
iction of longer-term prognosis is more challenging even with AI 
31] . 
The advent of Telemedicine and its empowerment by upcom- 
ng mobile devices (e.g. smartphones-watches, other remote sens- 
ng devices) will support early discharge protocols by guarantee- 
ng safety via close surveillance including remote rehabilitation 
69] .There is a plethora of platforms and hardware offering re- 
ote monitoring in particular for the detection of arrhythmias that 
s potentially helpful for early discharge after SHD interventions 
69–72] . Mobile devices also allow real-time transmission of blood 
ressure or other vital signs [72] . Early signs of pulmonary con- 
estion can be detected by a wearable vest with two sensors fos- 
ering early intervention and avoidance of hospital admission [67] . 
ccelerometers assessing daily step-count can monitor and pro- 
ote physical activity [72–74] . The setting of a remote surveillance 
nd rehabilitation program is challenging, as it demands the effi- 
ient incorporation of the collected data into the electronic health- 
ecords plus a structured and timely response to the incoming in- 
ormation. AI nevertheless is a way to endorse a patient-driven 
nd patient-tailored health care system. The creation of tele- and 
irtual-medicine centers such as the Mercy Virtual that launched a 
ingle-hub electronic intensive care unit (ICU) in the USA in 2006 
s an illustration thereof. It impacts those in need of care and those 
ho deliver care (continuous training, education, reorganization) 
s well as the health-care authorities. Proper positioning and ap- 
lication of AI in medicine demands a profound understanding of 
ts principles, strengths and pitfalls. 
hallenges in applying Artificial Intelligence in clinical practice 
ML algorithms development, validation and application share 
ome common grounds with conventional statistics [7] . First, as 
iscussed above, ML algorithms are vulnerable to bias and high- 
uality data are required for the generation of first-rate algorithms 
 8 , 14 , 75 ]. This is particularly an issue when very large datasets
ontaining unneeded and/or confounding variables are being used. 
ias is especially difficult to ascertain in DL algorithms, whose 
ethodology of data processing may be incomprehensible to the 
uman brain [ 7 , 75 ]. Secondly, the algorithms’ reproducibility needs 
o be assessed, and so far most evidence stems from single-center 
tudies lacking validation in different populations. On the other 
and, in some cases, different algorithms may be required for dif- 
erent populations [ 14 , 75 ]. For instance, cluster analysis in Amer- 
can AF patients yielded different phenotype clusters than in a 
apanese population, probably due to different environmental, cul- 
ural (including health system structure) and genetic factors. 29,30 
hirdly, the use of AI in clinical practice may be complicated by the 
act that the user may be unaware of how the output was created 
nd a clinical or pathophysiologic explanation of the associations 
ay be absent. Human intelligence needs artificial intelligence but 
he opposite is equally true to grasp the complexity of AI and 
ence ensure its appropriate application. Fourthly, digitalization of 
ealth records comes with privacy and data safety issues. A breach 
n security could jeopardize confidential information of millions of 
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atients [72–75] . However, the development of more robust algo- 
ithms, particularly those concerning less frequent pathologies or 
nterventions (such as TMVR) may require data sharing between 
nstitutions, adding complexity to the privacy issue. 
Steady incorporation of AI into clinical decision support sys- 
ems is envisioned by many, but may be still a distant reality. It 
mplies that robust algorithms are built and adequately validated 
nd that they are efficiently embedded in the institutional software 
o that they can be used in real-time by the healthcare providers 
ithout imposing a cumbersome change in daily routine [75] . Cur- 
ently, studies demonstrating the advantages and cost-effectiveness 
f AI algorithms over “traditional” clinical practice are lacking. AI 
lgorithms may eventually fail due to faulty design or inappropri- 
te application (population), irrespective of how robust they have 
hown in test-populations. It is therefore unclear how much hu- 
an supervision will be required and who will be held responsible 
n case of error – the healthcare provider or the company respon- 
ible for the technology [ 17 , 76 ]. It requires specific regulation as
ell as standardization of validation and approval of novel AI al- 
orithms. It also requires continuous training, education and infor- 
ation of all stakeholders of health care to overcome doubts and 
uspicions, concerns of inappropriate use and obsolescence of hu- 
an resources [4] . The purpose of AI is to ease their workflow by
or instance allowing the healthcare practitioners to dedicate more 
ime to tasks that cannot be performed by machines (personal con- 
act, humanization of healthcare) and to grant health accessibility 
o a larger number of patients. In the light of the above, we feel
hat human and artificial intelligence are complementary and that 
nal clinical decision-making is the responsibility of the physician 
ho has an understanding of the nature and pathophysiology of 
he AI-derived associations or predictions. 
onclusion 
AI is a promising tool for improving the delivery of care such 
s SHD-Interventions. Upon further research and development, it 
as the potential to enhance Precision Medicine in each step of 
he clinical pathway, including diagnosis, treatment stratification 
nd device selection, procedure execution and guidance and post- 
rocedural/discharge surveillance and rehabilitation. 
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